首页 | 本学科首页   官方微博 | 高级检索  
检索        


Population pharmacokinetics of subcutaneous C1‐inhibitor for prevention of attacks in patients with hereditary angioedema
Authors:Dipti Pawaskar  Michael A Tortorici  Bruce Zuraw  Timothy Craig  Marco Cicardi  Hilary Longhurst  H Henry Li  William R Lumry  Inmaculada Martinez‐Saguer  Joshua Jacobs  Jonathan A Bernstein  Marc A Riedl  Constance H Katelaris  Paul K Keith  Annette Feussner  Jagdev Sidhu
Institution:1. CSL Behring, King of Prussia, Pennsylvania;2. Department of Medicine, University of California San Diego and San Diego VA Healthcare, La Jolla, California;3. Department of Medicine, Pediatrics and Graduate Studies, Penn State University, Hershey, Pennsylvania;4. Dipartimento di Scienze Biomediche e Cliniche “L. Sacco”, Università Degli Studi Di Milano, Milan, Italy;5. Addenbrookes Hospital, Cambridge Universities NHS Foundation Trust, Cambridge, UK;6. Institute for Asthma and Allergy, Chevy Chase, Maryland;7. AARA Research CenterAllergy and Asthma Specialists, Dallas, Texas;8. Haemophilia Centre Rhine Main (HZRM), Moerfelden‐Walldorf, Germany;9. Allergy and Asthma Clinical Research Walnut Creek, Walnut Creek, California;10. Department of Immunology/Allergy, University of Cincinnati College of Medicine and Bernstein Clinical Research Center, Cincinnati, Ohio;11. Department of Medicine, Division of Rheumatology, Allergy & Immunology, University of California San Diego, San Diego, California;12. Department of Medicine, Campbelltown Hospital, Western Sydney University, Sydney, New South Wales, Australia;13. Department of Medicine, McMaster University, Hamilton, Ontario, Canada;14. CSL Behring, Marburg, Germany;15. CSL Limited, Parkville, Melbourne, Australia
Abstract:
Keywords:angioedema  clinical immunology  prevention
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号